304 related articles for article (PubMed ID: 18256395)
1. Neonatal diagnosis and treatment of Menkes disease.
Kaler SG; Holmes CS; Goldstein DS; Tang J; Godwin SC; Donsante A; Liew CJ; Sato S; Patronas N
N Engl J Med; 2008 Feb; 358(6):605-14. PubMed ID: 18256395
[TBL] [Abstract][Full Text] [Related]
2. Catecholamine metabolites affected by the copper-dependent enzyme dopamine-beta-hydroxylase provide sensitive biomarkers for early diagnosis of menkes disease and viral-mediated ATP7A gene therapy.
Kaler SG; Holmes CS
Adv Pharmacol; 2013; 68():223-33. PubMed ID: 24054147
[TBL] [Abstract][Full Text] [Related]
3. L-threo-dihydroxyphenylserine corrects neurochemical abnormalities in a Menkes disease mouse model.
Donsante A; Sullivan P; Goldstein DS; Brinster LR; Kaler SG
Ann Neurol; 2013 Feb; 73(2):259-65. PubMed ID: 23224983
[TBL] [Abstract][Full Text] [Related]
4. Clinical outcomes in Menkes disease patients with a copper-responsive ATP7A mutation, G727R.
Tang J; Donsante A; Desai V; Patronas N; Kaler SG
Mol Genet Metab; 2008 Nov; 95(3):174-81. PubMed ID: 18752978
[TBL] [Abstract][Full Text] [Related]
5. Molecular correlates of epilepsy in early diagnosed and treated Menkes disease.
Kaler SG; Liew CJ; Donsante A; Hicks JD; Sato S; Greenfield JC
J Inherit Metab Dis; 2010 Oct; 33(5):583-9. PubMed ID: 20652413
[TBL] [Abstract][Full Text] [Related]
6. Relative efficiencies of plasma catechol levels and ratios for neonatal diagnosis of menkes disease.
Goldstein DS; Holmes CS; Kaler SG
Neurochem Res; 2009 Aug; 34(8):1464-8. PubMed ID: 19234788
[TBL] [Abstract][Full Text] [Related]
7. Successful early copper therapy in Menkes disease associated with a mutant transcript containing a small In-frame deletion.
Kaler SG; Das S; Levinson B; Goldstein DS; Holmes CS; Patronas NJ; Packman S; Gahl WA
Biochem Mol Med; 1996 Feb; 57(1):37-46. PubMed ID: 8812725
[TBL] [Abstract][Full Text] [Related]
8. Novel mutations and clinical outcomes of copper-histidine therapy in Menkes disease patients.
Kim JH; Lee BH; Kim YM; Choi JH; Kim GH; Cheon CK; Yoo HW
Metab Brain Dis; 2015 Feb; 30(1):75-81. PubMed ID: 24919650
[TBL] [Abstract][Full Text] [Related]
9. Neurodevelopment and brain growth in classic Menkes disease is influenced by age and symptomatology at initiation of copper treatment.
Kaler SG
J Trace Elem Med Biol; 2014 Oct; 28(4):427-30. PubMed ID: 25281031
[TBL] [Abstract][Full Text] [Related]
10. In utero copper treatment for Menkes disease associated with a severe ATP7A mutation.
Haddad MR; Macri CJ; Holmes CS; Goldstein DS; Jacobson BE; Centeno JA; Popek EJ; Gahl WA; Kaler SG
Mol Genet Metab; 2012 Sep; 107(1-2):222-8. PubMed ID: 22695177
[TBL] [Abstract][Full Text] [Related]
11. ATP7A gene addition to the choroid plexus results in long-term rescue of the lethal copper transport defect in a Menkes disease mouse model.
Donsante A; Yi L; Zerfas PM; Brinster LR; Sullivan P; Goldstein DS; Prohaska J; Centeno JA; Rushing E; Kaler SG
Mol Ther; 2011 Dec; 19(12):2114-23. PubMed ID: 21878905
[TBL] [Abstract][Full Text] [Related]
12. Molecular and biochemical characterization of Mottled-dappled, an embryonic lethal Menkes disease mouse model.
Haddad MR; Patel KD; Sullivan PH; Goldstein DS; Murphy KM; Centeno JA; Kaler SG
Mol Genet Metab; 2014 Dec; 113(4):294-300. PubMed ID: 25456742
[TBL] [Abstract][Full Text] [Related]
13. Differences in ATP7A gene expression underlie intrafamilial variability in Menkes disease/occipital horn syndrome.
Donsante A; Tang J; Godwin SC; Holmes CS; Goldstein DS; Bassuk A; Kaler SG
J Med Genet; 2007 Aug; 44(8):492-7. PubMed ID: 17496194
[TBL] [Abstract][Full Text] [Related]
14. The T1048I mutation in ATP7A gene causes an unusual Menkes disease presentation.
León-García G; Santana A; Villegas-Sepúlveda N; Pérez-González C; Henrríquez-Esquíroz JM; de León-García C; Wong C; Baeza I
BMC Pediatr; 2012 Sep; 12():150. PubMed ID: 22992316
[TBL] [Abstract][Full Text] [Related]
15. Menkes disease and infantile epilepsy.
Prasad AN; Levin S; Rupar CA; Prasad C
Brain Dev; 2011 Nov; 33(10):866-76. PubMed ID: 21924848
[TBL] [Abstract][Full Text] [Related]
16. Screening of 383 unrelated patients affected with Menkes disease and finding of 57 gross deletions in ATP7A.
Tümer Z; Birk Møller L; Horn N
Hum Mutat; 2003 Dec; 22(6):457-64. PubMed ID: 14635105
[TBL] [Abstract][Full Text] [Related]
17. A Truncating De Novo Point Mutation in a Young Infant with Severe Menkes Disease.
Lin YJ; Ho CS; Hsu CH; Lin JL; Chuang CK; Tsai JD; Chiu NC; Lin HY; Lin SP
Pediatr Neonatol; 2017 Feb; 58(1):89-92. PubMed ID: 25771438
[TBL] [Abstract][Full Text] [Related]
18. Mutation in the CPC motif-containing 6th transmembrane domain affects intracellular localization, trafficking and copper transport efficiency of ATP7A protein in mosaic mutant mice--an animal model of Menkes disease.
Lenartowicz M; Grzmil P; Shoukier M; Starzyński R; Marciniak M; Lipiński P
Metallomics; 2012 Feb; 4(2):197-204. PubMed ID: 22089129
[TBL] [Abstract][Full Text] [Related]
19. Neonatal erythroderma as a first manifestation of Menkes disease.
Galve J; Vicente A; González-Enseñat MA; Pérez-Dueñas B; Cusí V; Møller LB; Julià M; Domínguez A; Ferrando J
Pediatrics; 2012 Jul; 130(1):e239-42. PubMed ID: 22711717
[TBL] [Abstract][Full Text] [Related]
20. [From gene to disease; Menkes disease: copper deficiency due to an ATP7A-gene defect].
Aldenhoven M; Klomp LW; van Hasselt PM; de Koning TJ; Visser G
Ned Tijdschr Geneeskd; 2007 Oct; 151(41):2266-70. PubMed ID: 17987894
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
